Express Scripts Holding (NASDAQ:ESRX) VP Glen D. Stettin sold 3,448 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total value of $262,048.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Express Scripts Holding (ESRX) opened at $76.01 on Friday. The firm has a market capitalization of $43,089.66, a PE ratio of 12.52, a P/E/G ratio of 1.01 and a beta of 0.87. Express Scripts Holding has a 12 month low of $55.80 and a 12 month high of $76.37. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61.
Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $1.90. The firm had revenue of $24.68 billion for the quarter, compared to analysts’ expectations of $25.68 billion. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. Express Scripts’s revenue was down 2.9% on a year-over-year basis. During the same quarter last year, the business posted $1.74 EPS. analysts expect that Express Scripts Holding will post 7.03 earnings per share for the current fiscal year.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Burt Wealth Advisors boosted its position in Express Scripts by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after acquiring an additional 174 shares during the period. Bank of Nova Scotia Trust Co. acquired a new stake in Express Scripts during the 3rd quarter worth about $120,000. First Personal Financial Services boosted its position in Express Scripts by 199.1% during the 2nd quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock worth $134,000 after acquiring an additional 1,400 shares during the period. Monroe Bank & Trust MI boosted its position in Express Scripts by 74.8% during the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after acquiring an additional 970 shares during the period. Finally, Capstone Investment Advisors Netherlands B.V. boosted its position in Express Scripts by 49.3% during the 2nd quarter. Capstone Investment Advisors Netherlands B.V. now owns 2,797 shares of the company’s stock worth $179,000 after acquiring an additional 924 shares during the period. Hedge funds and other institutional investors own 88.28% of the company’s stock.
A number of research analysts recently issued reports on ESRX shares. TheStreet raised Express Scripts from a “c+” rating to a “b-” rating in a report on Monday, December 4th. Zacks Investment Research raised Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 target price on the stock in a report on Monday, October 16th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Deutsche Bank started coverage on Express Scripts in a report on Monday, December 4th. They set a “buy” rating and a $75.00 target price on the stock. Finally, Jefferies Group reaffirmed a “buy” rating on shares of Express Scripts in a report on Thursday, October 26th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $75.84.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
What are top analysts saying about Express Scripts? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Express Scripts and related companies.